In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck KGAA's Hostile Bid Catalyzes Bayer-Schering Combo

Executive Summary

In March 2006, Bayer AG's €16.3 billion ($19.6 billion) cash offer for Schering trumped compatriot Merck KGAA's unsolicited €14.6 billion takeover bid for the specialist pharma marketer. The offers to acquire Schering put a spotlight on Europe's mid-sized players, most of which are either on the acquisition trail or putting up For Sale signs in front of corporate headquarters.
Advertisement

Related Content

European Consolidation: Serious Competition for Big Pharma?
Bayer Wins Specialty CV Deal
Will Pharma Split Spur Altana Into Action?
Will Pharma Split Spur Altana Into Action?
The Anti-Global, Specialist Strategy: Why Bayer's Choice Might Be Right for Other Pharmas
The Anti-Global, Specialist Strategy: Why Bayer's Choice Might Be Right for Other Pharmas
Schering: Addressing the Specialist Challenge
Schering: Addressing the Specialist Challenge
The Best Defense Is a Good Offense: Sanofi's Bid for Aventis
The Best Defense Is a Good Offense: Sanofi's Bid for Aventis

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel